Machine Learning-Driven Progressive Ligand Screening Reveals K-Ras-PDEdelta-IN-1 as a Promising G4 Stabilizer for Anti-Myeloma Therapy
RSC Medicinal Chemistry · 2026
DOI: 10.1039/d6md00633g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Jian Gao und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Drug repurposing offers a promising strategy for the treatment of multiple myeloma (MM), particularly through targeting the c-Myc promoter G-quadruplex (G4), a key transcriptional repressor element. In this study, we...
Zitieren
APA
Gao, J., Yang, M., Zhao, M., Yu, S., Li, H., & Cui, W. (2026). Machine Learning-Driven Progressive Ligand Screening Reveals K-Ras-PDEdelta-IN-1 as a Promising G4 Stabilizer for Anti-Myeloma Therapy. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00633g
Vancouver
Gao J, Yang M, Zhao M, Yu S, Li H, Cui W. Machine Learning-Driven Progressive Ligand Screening Reveals K-Ras-PDEdelta-IN-1 as a Promising G4 Stabilizer for Anti-Myeloma Therapy. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00633g
BibTeX
@article{Gao2026,
author = {Gao, Jian and Yang, Mo and Zhao, Manqing and Yu, Siqi and Li, Huanyu and Cui, Wei},
title = {Machine Learning-Driven Progressive Ligand Screening Reveals K-Ras-PDEdelta-IN-1 as a Promising G4 Stabilizer for Anti-Myeloma Therapy},
journal = {RSC Medicinal Chemistry},
year = {2026},
doi = {10.1039/d6md00633g}
}
EUVIMED